Today: 23 May 2025
25 March 2021
2 mins read

EU revises vaccine export system

The principle of reciprocity will be applied to non-EU countries having at their disposal a large production capacity…reports Asian Lite News.

The European Commission presented a revised version of its export transparency mechanism for Covid-19 vaccines, with Executive Vice President Valdis Dombrovskis claiming that it does not constitute an export ban.

The mechanism takes aim at vaccines produced in European Union (EU)-based facilities of pharmaceutical companies that are bound by an advance purchase agreement (APA) with the EU. The new version includes two new criteria — reciprocity and proportionality — for assessing whether these vaccines can be exported to non-EU countries, according to Dombrovskis, Xinhua news agency reported on Wednesday.

The principle of reciprocity will be applied to non-EU countries having at their disposal a large production capacity. The European Commission and the EU member states will examine if the flow of imports and exports of vaccine and vaccine substances between the bloc and destination country is even.

Proportionality is about finding the right balance, the commissioner explained. The European Commission and the member states will take into account the specific situation of the country of destination, including its vaccination rate and the existing availability of Covid-19 vaccines.

AstraZeneca vaccine

Vaccine exports towards low- and middle-income countries covered by the COVAX (Covid-19 Vaccines Global Access) facility remain exempted.

Put in place on January 30, the export and transparency mechanism was launched when the EU argued that some pharmaceutical companies failed to honor their commitments to deliver the promised amount of doses to the EU countries but still could export vaccines from their EU-based facilities.

Originally due to expire on March 12, the mechanism has been extended until June 30.

(Photo: Pallav Paliwal)

A total of 381 export requests have been introduced by pharmaceutical companies bound by an APA with the EU, and only one has been declined.

AstraZeneca, a British-Swedish vaccine manufacturer, had applied to export 250,000 doses of its Covid-19 vaccine to Australia, while falling behind its delivery schedule for the EU.

“I remind you that AstraZeneca has only delivered a small portion of its agreed contractual commitments,” Dombrovskis said.

Also Read-EU leaders summit turns digital

Read More-EU sanctions China over Uighur abuses

Previous Story

Germany cancels plan for Easter lockdown

Next Story

Russia asks NATO to deal own problems

Latest from -Top News

UAE bakery aid reaches Gaza

The convoy is a crucial component of the UAE’s ongoing humanitarian strategy under Operation Chivalrous Knight 3, which prioritises urgent food aid. A major humanitarian relief convoy has successfully entered the Gaza

Tech giants unite for Stargate UAE

This marks the beginning of a strategic partnership involving G42, OpenAI, Oracle, NVIDIA, Cisco, and SoftBank Group, all coming together under the banner of international AI leadership. In a landmark announcement that

‘Make It in Emirates’ boosts Dh11b projects

The event welcomed more than 122,000 visitors — a 20-fold increase over its previous edition — and drew participation from over 720 local and international industrial, financial, and technology entities. The fourth

UAE leads Arab health push in Genevaa

UAE Health Minister Al Owais highlights Arab unity at WHO Assembly, reaffirming commitment to global health, crisis response, and sustainable healthcare innovation for the future. The UAE underscored its regional leadership in

Will tackle terrorism together: UAE backs India 

The UAE reaffirmed strong support for India’s fight against terrorism during a high-level Indian delegation visit, highlighting shared security goals and condemning cross-border terrorism after the Pahalgam attack. In a powerful show
Go toTop

Don't Miss

Bangladesh to buy Chinese vaccines

Earlier, the country had received seven million Covishield doses through

Global Covid caseload tops 269.6 mn

The global coronavirus caseload has topped 269.6 million, while the